[EN] TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS<br/>[FR] ANTAGONISTES OPIOÏDES KAPPA DE TÉTRAHYDROISOQUINOLINE
申请人:RES TRAINGLE INSTITUTE
公开号:WO2018053222A1
公开(公告)日:2018-03-22
Potent opioid receptor antagonists of formula (I) and their use as pharmacotherapies for treating depression, anxiety, schizophrenia, eating disorders, and addiction to cocaine, methamphetamine, nicotine, alcohol, and opiates are disclosed. More specifically, the disclosure provides potent and selective kappa opioid receptor antagonist compounds, pharmaceutical compositions of those compounds and uses of those compounds to ameliorate or treat addictions, eating disorders, etc.